No immediate trading implications. Monitor future Form 4 filings for actual insider transactions. The granting of power of attorney is procedural and does not indicate trading intent.
Price Chart
Executive Summary
Cheryl Blanchard, a reporting person at Xilio Therapeutics, filed a Form 3 indicating initial beneficial ownership and granted a power of attorney to several individuals to act on her behalf in SEC filings and EDGAR account management. This is a routine administrative filing with no direct financial impact.
Key Facts
- Cheryl Blanchard filed a Form 3, indicating initial beneficial ownership of Xilio Therapeutics securities.
- She granted power of attorney to Mark Andrew Devine, Caroline Hensley, Elana Brockmann, René Russo, Christopher Frankenfield, and Kevin Brennan to handle SEC filings and EDGAR account administration on her behalf.
- The power of attorney includes authority to file Forms 3 and 4, manage EDGAR access, and act as account administrator, effective April 14, 2026.
Financial Impact
No direct financial impact disclosed; this is an administrative filing related to reporting obligations.
Risk Factors
- Potential for future insider transactions to be executed by attorneys-in-fact without direct oversight, though standard for compliance efficiency.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-159314 |
| Document: 0001193125-26-159314-index-headers.html | 0001193125-26-159314 |
| Document: 0001193125-26-159314-index.html | 0001193125-26-159314 |
| Document: 0001193125-26-159314.txt | 0001193125-26-159314 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | Press Release | — | awaiting T+5 | — | — |
Aug 12, 2026 10w ago | 8-K | $9.05 $9.41 | ▲ +3.98% | ▲ +4.42% | $8.16 (−9.81%) |
Aug 12, 2026 10w ago | Press Release | $9.05 $9.41 | ▲ +3.98% | ▲ +4.42% | $8.16 (−9.81%) |
Jun 1, 2026 21w ago | EFFECT | $8.25 $7.70 | ▲ +6.67% | ▲ +3.92% | $8.16 (+1.06%) |
May 27, 2026 21w ago | S-3/A | $8.52 $8.15 | ▼ −4.40% | ▼ −4.35% | $8.16 (−4.20%) |
May 12, 2026 23w ago | 8-K | $7.73 $8.15 | ▲ +5.43% | ▲ +5.36% | $8.16 (+5.60%) |
May 12, 2026 23w ago | Press Release | $7.73 $8.15 | ▲ +5.43% | ▲ +5.36% | $8.16 (+5.60%) |
Apr 17, 2026 27w ago | Press Release | $8.45 $8.18 | ▼ −3.20% | ▼ −4.11% | $8.16 (−3.40%) |
Apr 16, 2026 27w ago | 3 | $8.57 $8.31 | ▼ −3.03% | ▼ −3.59% | $8.16 (−4.75%) |
Apr 16, 2026 27w ago | 8-K | $8.35 $8.47 | ▲ +1.44% | ▲ +0.45% | $8.16 (−2.25%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers